Geode Capital Management
AGL icon

Geode Capital Management’s Agilon Health AGL Stock Holding History

Geode Capital Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.7M Buy
314,165
+48,053
+18% +$3.15M ﹤0.01% 1851
2026
Q1 		$2.11M Sell
266,112
-20,987
-7% -$339K ﹤0.01% 3098
2025
Q4 		$4.94M Buy
287,099
+1,402
+0.5% +$27.2K ﹤0.01% 2781
2025
Q3 		$7.36M Sell
285,697
-562
-0.2% -$21.2K ﹤0.01% 2585
2025
Q2 		$16.5M Buy
286,259
+7,139
+3% +$573K ﹤0.01% 2058
2025
Q1 		$30.2M Buy
279,120
+1,971
+0.7% +$172K ﹤0.01% 1669
2024
Q4 		$13.2M Buy
277,149
+1,408
+0.5% +$85.1K ﹤0.01% 2190
2024
Q3 		$27.1M Buy
275,741
+3,396
+1% +$439K ﹤0.01% 1817
2024
Q2 		$44.5M Buy
272,345
+86,200
+46% +$12.3M ﹤0.01% 1444
2024
Q1 		$28.4M Buy
186,145
+6,587
+4% +$1.1M ﹤0.01% 1717
2023
Q4 		$56.3M Buy
179,558
+7,604
+4% +$2.75M 0.01% 1269
2023
Q3 		$76.4M Buy
171,954
+11,553
+7% +$5.22M 0.01% 937
2023
Q2 		$69.5M Buy
160,401
+58,279
+57% +$32.8M 0.01% 1016
2023
Q1 		$60.6M Buy
102,122
+3,373
+3% +$1.89M 0.01% 1051
2022
Q4 		$39.8M Buy
98,749
+5,549
+6% +$2.6M 0.01% 1307
2022
Q3 		$54.6M Buy
93,200
+51,067
+121% +$30.6M 0.01% 1019
2022
Q2 		$23M Buy
42,133
+2,425
+6% +$1.23M ﹤0.01% 1666
2022
Q1 		$25.2M Buy
39,708
+2,262
+6% +$1.17M ﹤0.01% 1731
2021
Q4 		$25.3M Buy
37,446
+12,774
+52% +$7.77M ﹤0.01% 1796
2021
Q3 		$16.2M Buy
24,672
+2,806
+13% +$2.4M ﹤0.01% 2103
2021
Q2 		$22.2M Buy
+21,866
New +$19.2M ﹤0.01% 1895

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management's AGL Position: Q2 2026 in Review

Geode Capital Management increased its Agilon Health (AGL) stake by 18% in Q2 2026, buying an estimated $3.15M and bringing the position to 314,165 shares worth $33.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1851.

Geode Capital Management first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. The position peaked at $76.4M in Q3 2023. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Geode Capital Management held 314,165 shares of Agilon Health worth $33.7M as of Q2 2026.
  • Geode Capital Management bought 48,053 Agilon Health shares in Q2 2026, an estimated $3.15M.
  • Agilon Health made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1851 holding.
  • Geode Capital Management first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Agilon Health position peaked at $76.4M in Q3 2023.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.